Higher Scientific Officer - Target Validation and Genome Stability Group

TN United Kingdom; Greater London; On-site; GBP 35,000 - 55,000; Full time

Job summary

An established industry player is looking for a Higher Scientific Officer to join their dynamic Target Validation and Genome Stability Group in Sutton. In this exciting role, you will conduct vital lab-based cell biology research aimed at identifying therapeutic targets in breast cancer. You will be responsible for developing assays and discovering biomarkers that will play a crucial role in the drug discovery process. This position offers a supportive research environment with access to cutting-edge facilities and opportunities for professional development. Join a team of leading researchers and make a significant impact in the fight against breast cancer.

Benefits

Dynamic Research Environment

Access to State-of-the-Art Facilities

Professional Development Opportunities

Collaboration with Leading Researchers

Competitive Salary

Pension Plan

Qualifications

• MSc (or equivalent) in cell biology or related field.
• Skills in cell biology techniques for target validation.

Responsibilities

• Conduct lab-based cell biology research focused on breast cancer.
• Develop assays and discover biomarkers for drug targets.

Skills

Cell Biology Techniques

Biomarker Detection

Assay Development

Education

MSc in Cell Biology

Equivalent Degree

Job description

Higher Scientific Officer - Target Validation and Genome Stability Group, Sutton

The Institute of Cancer Research is seeking a Higher Scientific Officer to join the Target Validation and Genome Stability Group in Sutton, UK. Under the guidance of Prof Joanna Loizou, the successful candidate will conduct lab-based cell biology research focused on potential therapeutic targets in breast cancer. Responsibilities include assay development and biomarker discovery for targets moving to drug discovery phases.

About you

The ideal candidate will have:

• An MSc (or equivalent) in cell biology or a related field
• Skills in cell biology techniques used for target validation
• Expertise in biological readouts for screening and biomarker detection

Department/Directorate Information

The Target Validation and Genome Stability Group, led by Professor Joanna Loizou, focuses on identifying vulnerabilities in the DNA damage response to generate pre-clinical data for novel drug targets. The group is part of the Breast Cancer Now Toby Robins Research Centre within the Division of Breast Cancer Research at The Institute of Cancer Research, the UK's first dedicated breast cancer research centre.

What we offer

• A dynamic and supportive research environment
• Access to state-of-the-art facilities and professional development opportunities
• Collaboration with leading researchers
• Competitive salary and pension